I-MAB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.47 EUR | +3.52% |
|
-11.25% | -12.88% |
| 06-06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
| 06-05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
- Stock Market
- Equities
- IMAB Stock
- 0VY Stock
- News I-Mab
- Trading Ideas
